Relapsed Synovial Sarcoma: Treatment Options.
Mia C WeissBrian A Van TinePublished in: Current treatment options in oncology (2023)
Synovial sarcoma (SS) is a fusion-driven subtype of sarcoma that is a more chemo-sensitive subtype of soft tissue sarcoma. While chemotherapy options are currently standard of care, our fundamental understanding of the biology of SS is driving new therapies. We will review the current standard of care, as well as the current therapies showing promise in a clinical trial. It is our hope that by encouraging participation in clinical trials, the fundamental therapies available for SS will change the current treatment paradigm.
Keyphrases
- clinical trial
- healthcare
- palliative care
- phase ii
- acute myeloid leukemia
- locally advanced
- physical activity
- combination therapy
- diffuse large b cell lymphoma
- pain management
- study protocol
- affordable care act
- radiation therapy
- double blind
- multiple myeloma
- open label
- machine learning
- hodgkin lymphoma
- health insurance